openPR Logo
Press release

Drug Discovery Informatics Market Size, Share, Growth, Trends and Industry Analysis 2022-2027

08-25-2022 06:45 PM CET | Health & Medicine

Press release from: IMARC Group

Drug Discovery Informatics Market Size, Share, Growth, Trends

According to IMARC Group's latest report, titled "Drug Discovery Informatics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", the global drug discovery informatics market size reached US$ 2.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.1 Billion by 2027, exhibiting a CAGR of 11.62% during 2022-2027.

COVID-19 Impact Analysis:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Download Free Report Sample Brochure: https://www.imarcgroup.com/drug-discovery-informatics-market/requestsample

Industry Overview and Application:

Drug discovery informatics (DDI) is a technical solution utilized for discovering new treatments and developing effective medications through comprehensive research and screenings. It uses sophisticated bioinformatics algorithms to process biomechanical data related to drugs, proteins, diseases, pathways, gene expression, and sequence data. It also encompasses various hardware and software-based solutions for protecting databases and researching, docking, interpreting, visualizing, and preparing drug formulations cost-effectively. Besides this, DDI analyses new drug entities, handles biological information from multiple sources, and performs several pharmacovigilance tasks and clinical decisions post trials.

Market Trends and Drivers:

The increasing prevalence of various chronic disorders, especially amongst the geriatric population, and the growing need for effective medicines at affordable prices are driving the drug discovery informatics market growth. Additionally, the outbreak of the coronavirus disease (COVID-19) pandemic has prompted governments to invest in the pharmaceutical industry to formulate vaccines, which, in turn, is augmenting the product demand. Apart from this, substantial improvements in the healthcare infrastructure, the advent of in-silico tools and physiologically based pharmacokinetic (PBK) simulator to select pediatric doses, and ongoing research and development (R&D) activities to enhance the drug discovery informatics efficacy are supporting the market growth.

Drug Discovery Informatics Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the drug discovery informatics market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

• Certara
• Charles River Laboratories Inc.
• Collaborative Drug Discovery Inc.
• Eurofins DiscoverX Products
• Infosys Ltd.
• International Business Machines Corporation
• Jubilant Biosys Limited
• Oracle Corporation
• PerkinElmer Inc.
• Selvita
• Thermo Fisher Scientific Inc.

Key Market Segmentation:

The report has segmented the global drug discovery informatics market on the basis of workflow, function, mode, end user and region.

Breakup by Workflow:

• Drug Discovery
• Drug Development

Breakup by Function:

• Sequence Analysis Platforms
• Molecular Modeling
• Molecular Docking
• Clinical Trial Data Management
• Others

Breakup by Mode:

• Outsourced
• In-house

Breakup by End User:

• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organization (CROs)
• Others

Breakup by Region:

• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=3515&flag=C

Key Highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Discovery Informatics Market Size, Share, Growth, Trends and Industry Analysis 2022-2027 here

News-ID: 2716888 • Views:

More Releases from IMARC Group

Frozen Food Distribution Business Plan Opportunities in 2025: Why Now is the Right Time to Invest
Frozen Food Distribution Business Plan Opportunities in 2025: Why Now is the Rig …
Frozen Food Distribution Business Plan & Project Report Overview IMARC Group's "Frozen Food Distribution Business Plan and Project Report 2025" offers a comprehensive framework for establishing a successful frozen food distribution business. The critical areas, including market trends, investment opportunities, revenue models, and financial forecasts, are discussed in this in-depth report and are therefore useful resources to entrepreneurs, consultants and investors. Whether evaluating the viability of a new venture or streamlining
Furniture Rental Business Plan Startup Costs and Profit Margins in 2025 Explained
Furniture Rental Business Plan Startup Costs and Profit Margins in 2025 Explaine …
Furniture Rental Business Plan & Project Report Overview IMARC Group's "Furniture Rental Business Plan and Project Report 2025" offers a comprehensive framework for establishing a successful furniture rental business. The critical areas, including market trends, investment opportunities, revenue models, and financial forecasts, are discussed in this in-depth report and are therefore useful resources to entrepreneurs, consultants and investors. Whether evaluating the viability of a new venture or streamlining an existing one,
3D Printing Materials Manufacturing Cost Report 2025: Plant Setup Economics and Financial Outlook
3D Printing Materials Manufacturing Cost Report 2025: Plant Setup Economics and …
3D printing materials are specialized substances used in additive manufacturing to create three-dimensional objects layer by layer. These materials come in various forms such as plastics, resins, metals, ceramics, and composites, each designed to meet specific performance, strength, and durability requirements. They play a critical role in determining the quality, accuracy, and functionality of the final product, making them essential in industries like aerospace, automotive, healthcare, construction, and consumer goods. Setting
Finishing School Business Plan Industry Trends 2025: Key Insights for Owners and Investors
Finishing School Business Plan Industry Trends 2025: Key Insights for Owners and …
Finishing School Business Plan & Project Report Overview IMARC Group's "Finishing School Business Plan and Project Report 2025" offers a comprehensive framework for establishing a successful finishing school business. The critical areas, including market trends, investment opportunities, revenue models, and financial forecasts, are discussed in this in-depth report and are therefore useful resources to entrepreneurs, consultants and investors. Whether evaluating the viability of a new venture or streamlining an existing one,

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase